14.97
1.56%
0.23
시간 외 거래:
14.70
-0.27
-1.80%
전일 마감가:
$14.74
열려 있는:
$14.62
하루 거래량:
27,142
Relative Volume:
0.55
시가총액:
$1.40B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
+11.14%
6개월 성능:
-1.12%
1년 성능:
+0.00%
Gyre Therapeutics Inc Stock (GYRE) Company Profile
명칭
Gyre Therapeutics Inc
전화
(619) 949-3681
주소
12770 HIGH BLUFF DRIVE, SUITE 150, SAN DIEGO
Gyre Therapeutics Inc Stock (GYRE) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2021-04-29 | 재개 | Stephens | Overweight |
2021-02-10 | 개시 | Piper Sandler | Overweight |
2020-05-21 | 개시 | Raymond James | Outperform |
2019-01-04 | 개시 | Oppenheimer | Outperform |
2018-02-12 | 재확인 | B. Riley FBR, Inc. | Buy |
2018-02-09 | 재확인 | Chardan Capital Markets | Buy |
2017-12-08 | 개시 | B. Riley FBR, Inc. | Buy |
2017-06-12 | 개시 | Chardan Capital Markets | Buy |
2017-06-06 | 개시 | Ladenburg Thalmann | Buy |
2016-06-30 | 개시 | Rodman & Renshaw | Buy |
모두보기
Gyre Therapeutics Inc 주식(GYRE)의 최신 뉴스
Gyre Therapeutics Announces Last Patient Completed Pivotal Phase 3 Trial Evaluating F351 for CHB-Associated Liver Fibrosis - The Manila Times
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 3.8%What's Next? - MarketBeat
AQR Capital Management LLC Invests $778,000 in Mativ Holdings, Inc. (NYSE:MATV) - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap UpStill a Buy? - MarketBeat
Aligos Therapeutics (NASDAQ:ALGS) Shares Down 6.2% - Defense World
Coronation Fund Managers Ltd. Buys 1,044 Shares of The Sherwin-Williams Company (NYSE:SHW) - Defense World
Eaton Vance California Municipal Income Trust (NYSE:CEV) Major Shareholder Sells $282,451.70 in Stock - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Trading 3.3% HigherHere's What Happened - MarketBeat
Gyre Therapeutics to Present at 8th Annual H.C. Wainwright MASH Investor Conference - The Manila Times
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Down 7.0% in August - MarketBeat
Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday - Benzinga
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 4.9% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Trading Up 6.6% - MarketBeat
Gyre Therapeutics Inc (GYRE) Stock Price & Chart | Trade Now - Capital.com
Gyre Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 8.9% - MarketBeat
Short Interest in Gyre Therapeutics, Inc. (NASDAQ:GYRE) Grows By 5.4% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Trading 4.1% Higher - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 6.6% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Sees Unusually-High Trading Volume - MarketBeat
Bicara Therapeutics (NASDAQ:BCAX) Stock Quotes, Forecast and News Summary - Benzinga
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Sees Significant Growth in Short Interest - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 8.2% - MarketBeat
Vanguard Group Inc. Reduces Holdings in Gyre Therapeutics, Inc. (NASDAQ:GYRE) - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Shares Gap Up to $10.40 - MarketBeat
GYRE Stock Earnings: Gyre Therapeutics Reported Results for Q2 2024 - InvestorPlace
Gyre Therapeutics (NASDAQ:GYRE) Trading Down 3.9% - MarketBeat
Gyre Therapeutics Reports Second Quarter 2024 and Year-To-Date Financial Results and Provides Business Update - BioSpace
Gyre Therapeutics (NASDAQ:GYRE) Trading 6.7% Higher - MarketBeat
Gyre Therapeutics to Present at Sidoti Virtual Investor Conference - ForexTV.com
Gyre Therapeutics Welcomes Dr. Epstein to Leadership Team - TipRanks
Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors - StockTitan
Gyre Therapeutics (NASDAQ:GYRE) versus Insmed (NASDAQ:INSM) Critical Comparison - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 8.4% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 18.9% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 8.4% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Trading Up 4.9% - MarketBeat
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Up 67.9% in July - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Shares Down 4.3% - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Trading Down 4.3% - MarketBeat
Gyre Therapeutics, Inc. (NASDAQ:GYRE) Short Interest Update - Defense World
Supply@ME Capital (LON:SYME) Stock Price Up 16.7% - Defense World
Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Short Interest Update - Defense World
Head to Head Comparison: Puma Biotechnology (NASDAQ:PBYI) versus Gyre Therapeutics (NASDAQ:GYRE) - Defense World
Adaptimmune Therapeutics plc (NASDAQ:ADAP) Short Interest Up 15.1% in June - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Up 5.5% - Defense World
Gyre Therapeutics (NASDAQ:GYRE) Stock Price Down 4.3% - MarketBeat
Gyre Therapeutics (NASDAQ:GYRE) Shares Up 3.7% - Defense World
Gyre Therapeutics faces Nasdaq delisting over audit rule - Investing.com India
Gyre Therapeutics faces Nasdaq delisting over audit rule By Investing.com - Investing.com
Gyre Therapeutics Seeks Compliance Amid Board Reshuffle - TipRanks
Gyre Therapeutics Inc (GYRE) 재무 분석
Gyre Therapeutics Inc (GYRE)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Gyre Therapeutics Inc 주식 (GYRE) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
USMAN NASSIM | Director |
Jun 28 '24 |
Sale |
12.00 |
3,452 |
41,438 |
1,636 |
USMAN NASSIM | Director |
May 01 '24 |
Option Exercise |
6.93 |
20,000 |
138,600 |
21,636 |
USMAN NASSIM | Director |
May 01 '24 |
Sale |
14.13 |
20,000 |
282,577 |
1,636 |
USMAN NASSIM | Director |
Apr 01 '24 |
Option Exercise |
6.93 |
20,000 |
138,600 |
21,636 |
USMAN NASSIM | Director |
Apr 01 '24 |
Sale |
16.15 |
20,000 |
323,000 |
1,636 |
USMAN NASSIM | Director |
Mar 15 '24 |
Option Exercise |
6.93 |
20,000 |
138,600 |
21,636 |
USMAN NASSIM | Director |
Mar 15 '24 |
Sale |
17.26 |
20,000 |
345,200 |
1,636 |
자본화:
|
볼륨(24시간):